期刊文献+

两种不同腔内后装施源器治疗宫颈癌的临床观察 被引量:4

The clinical observation of the treatment of the cervical cancer with two different after loading applicator
下载PDF
导出
摘要 目的:探讨高剂量率192Ir腔内后装时不同施源器治疗宫颈癌的疗效及膀胱、肠道晚反应并发症的发生情况。方法:127例宫颈癌患者予全盆外照DT45~50Gy配合腔内后装治疗,依照后装治疗时不同施源器分为固定Ⅲ管组62例,单宫腔管组65例。固定Ⅲ管组开始于全盆外照DT33Gy/18次,A点DT5~7Gy/次,1次/周,总量24~25Gy,6~8周内完成治疗。单宫腔管组开始于外照全盆DT38Gy/20次,A点DT6~7Gy/次,1次/周,总量21~25Gy,7~8周内完成治疗。结果:放疗结束后固定Ⅲ管组与单宫腔管组完全缓解病例分别为57例(91.94%)和58例(89.23%),5年生存率分别为66.13%(41/62)和61.50%(40/65),固定Ⅲ管组膀胱、肠道晚反应发生率分别为4.83%(3/62)和9.67%(6/62),明显低于单宫腔管组的10.76%(7/65)和21.53%(14/65)。结论:使用剂量曲线分布合理的固定Ⅲ管施源器行腔内放疗可以有效地治疗宫颈癌,并可明显减少膀胱、肠道晚反应并发症。 Objective:To explore the efficacy of uterine cervical cancer and late reaction complications of rectum and bladder with two different high dose rate 192 Ir afterloading intracavitary radiotherapy. Methods : One hundred and twenty-seven cases of cervical cancer were treated by the combination of the whole pelvis external radiotherapy and afterloading technique. After the Dt 45-50Gy of the external radiation, they were randomly allocated into two groups according to the different brachytheraputie modality: the fixed threetube applicator group(62 patients) and single-tube applicator group (65 patients). After the irradiation of whole pelvis with 50Gy, high dose rate intracavitary brachytherapy(HDRICB) with 192 Ir was performed using afterloading technique. The prescribed "Point A" dose in fixed three tube group were ranged from 5-7 Gy once a week, for 6-8 weeks, with the total dose of 24-25 Gy. And the "Point A" dose in single tube group were ranged from 6-TGy once a week, for 7-8 weeks, with the total dose of 21-25Gy. Results:After the radiotherapy, the cases of patients who got a complete remmision in the two groups were 57 (91.94%) and 58 (89.23%) , respectively. The total 5 year survival rate of two groups was 66. 13 % (41/62 ) and 61.50% (40/65), respectively, which were very close. The incidence of radiation cystitis and rectitis in fixed three-tube applicator group was 5% and 10% respectively, and that of single-tube applicator group was 11% and 21% , respectively. The difference was significant between two groups. Conclusion: The radiation dose curve in the fixed three-tube brachytherapy was more rational than that of the single-tube one and the late complication of rectum and bladder were obviously decreased by that way.
出处 《临床肿瘤学杂志》 CAS 2008年第12期1115-1118,共4页 Chinese Clinical Oncology
关键词 宫颈癌 腔内近距离放疗 放射性膀胱炎 放射性直肠炎 Cervical carcinoma Intracavitary brachytherapy Irradiation rectitis Irradiation cystitis
  • 相关文献

参考文献8

  • 1International Commission of Radiation Units and Measurements. ICRU report 38 : Dose and volume specification for reporting intracavitary therapy in gynecology [ M ]. Bethesda: International Commission of Radiation Units and Measurements, 1985:1 - 18.
  • 2Nag S, Erickson B,Thomadsen B, et al. The American brachytherapy society recommendations for high dose rate brachytherapy for carcinoma of the cervix[ J]. Int J Radiat Oncol Biol Phys,2000, 48(1) :201 -211.
  • 3孙建衡.妇科恶性肿瘤放射疗法现状[J].中国医学科学院学报,2003,25(4):481-483. 被引量:11
  • 4Nag S, Orton C, Young D, et al. The American brachytherapy society survey of brachytherapy practice for carcinoma of the cervix in the United States [J]. Gynecol Oncol, 1999,73 ( 1 ) : 111 -118.
  • 5李爱玲,孙建衡,张蓉,章文华,耿毅.子宫颈癌放射治疗512例临床报告[J].中华妇产科杂志,2000,35(5):303-304. 被引量:59
  • 6Hamberger AD, Unal A, Gershenson DM, et al. Analysis of the sever complications of irradiation of carcinoma of the cervix: whole pelvis irradiation and intracavitary radium[ J]. Int J Radiat Oncol Biol Phys, 1983,9:367 -371.
  • 7杨伟志.正常组织放射损伤[M]∥殷蔚伯,谷铣之.肿瘤放射治疗学.北京:中国协和医科大学出版社,2002:307-320.
  • 8Rao GG, Rogars P, Drake RD,et al. Phase Ⅰ clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer [ J ]. Gynecol Oncol, 2005,96 (1) :168.

二级参考文献13

共引文献70

同被引文献19

  • 1刘孜,罗伟,王国庆,王蕊华,郑伟,杨晓娟,高彩霞,王娟.中晚期宫颈癌后装腔内放疗剂量分布影响因素探讨[J].中华放射肿瘤学杂志,2006,15(6):444-447. 被引量:15
  • 2余健,张国楠,樊英.同步放化疗治疗中晚期宫颈癌50例临床疗效观察[J].实用妇产科杂志,2007,23(5):287-289. 被引量:74
  • 3殷莉萍,赵瑞,徐红.阴道冲洗在宫颈癌放疗中的效果观察[J].第四军医大学学报,2007,28(13):1180-1180. 被引量:5
  • 4连丽娟,刘彤华,刘炽明,等.林巧稚妇科肿瘤学[M].3版.北京:人民卫生出版社,2001,329-372.
  • 5Rosa Tombaro Giovann Scambia Massimo D;Maio,et al . The role of chemotherapy in locally advanced , metastatil and recurret cervical[J]. Critical Reviews in Oneology/Hematology ,2004, 52 ; 33.
  • 6Rose PG , Bundy BN ,Watkins EB , et al . Concurrent cisplation based radio therapy comared with pelvic and para_caortic radiation for high_risk cervical cancer [ J ] . N Engl J Med ,1999,340(15) :1 157.
  • 7Onishi H, Yamaguchi M, Kuriyama K, et al. Affect of concurrent intra - arterial infusion of platinum drugs for patients with stage HI or IV uterine cervical cancer treated with radical radioation therapy [ J ]. Cancer J Sci Am,2000,6 ( 1 ) :40.
  • 8黄曼妮,于国瑞,殷蔚伯,等.肿瘤放射治疗学[M].北京:中国协和医科大学出版社,2008:1007-1048.
  • 9ICRU第38份报告:妇科学腔内治疗的剂量和容积规格参数[M].贝塞斯达:国际辐射学单位委员会,1985:1-18.
  • 10纳格 S,埃里克森 B,托马德森 B,等.全美近距离放疗协会宫颈癌高剂量率近距离放疗的推荐规范[J].肿瘤放射生物生理学杂志,2000,48(1):201-211.

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部